Training of Eye Movements in Glaucoma
EyeYoga
Alternative Home Training Possibilities for Glaucoma Patients
1 other identifier
interventional
40
1 country
2
Brief Summary
The aim of the trial is to investigate the possibilities of improving visual impairments with eye training exercises (eye-yoga) in a total of 40 patients with glaucoma who have not previously been treated within a similar training program. 20 patients will be instructed how to do eye yoga to be performed dails for 4 weeks (max 30 min/day). As a control group of 20 patients will be instructed to read for 30 min/day for 4 weeks. The following outcome measures will be investigated: High Resolution Perimetry, Humphrey Perimetry, Visual Acuity Test, Contrast Sensitivity Test, Microsaccades measurements, Intraocular Pressure Measurement, Electroencephalogram (EEG), Blood Pressure and Pulse Measurement and Dynamic Vessel Analysis (DVA - the blood supply in the eye (especially vascular dysregulation) . Furthermore, factors that could influence response variability and the effectiveness of treatment will be analysed: (i) the role of mental stress (or stress resilience) and (ii) the influence of personality traits and quality of life. The study is intended to further validate this home training program (eye yoga) for the treatment of visual impairment in glaucoma.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2019
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 3, 2019
CompletedFirst Posted
Study publicly available on registry
July 30, 2019
CompletedStudy Start
First participant enrolled
August 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2023
CompletedFebruary 9, 2021
February 1, 2021
3.4 years
July 3, 2019
February 4, 2021
Conditions
Outcome Measures
Primary Outcomes (2)
Visual field size determined by perimetry measurements
Changes of the visual field's size, evaluated by static perimetry and high resolution perimetry measurements
4 weeks
Microsaccade measurements
Changes in the deviation of eye movements when visual targets are followed, using a computerized test
4 weeks
Secondary Outcomes (2)
Blood circulation in the eye
4 weeks
EEG connectivities
4 weeks
Study Arms (2)
Eye Yoga group
ACTIVE COMPARATOREye yoga exercises
Reading Group
PLACEBO COMPARATORPassive reading
Interventions
Eligibility Criteria
You may qualify if:
- clinical diagnosis of glaucoma
- residual vision
- the duration of the disease must be at least 6 months old
- the visual field defect must be stable
You may not qualify if:
- autoimmune diseases in the acute stage
- neurological and mental diseases
- diabetic retinopathy
- addictions
- hypertension (maximum 160/100 mmHg)
- retinitis pigmentosa-
- pathological nystagmus
- non-distant tumors or recurrent tumors
- photosensitivity
- pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Inst. of Medical Psychology, Univ. of Magdeburg
Magdeburg, 39120, Germany
Institute of Medical Psychology
Magdeburg, 39120, Germany
Related Publications (3)
Dada T, Mittal D, Mohanty K, Faiq MA, Bhat MA, Yadav RK, Sihota R, Sidhu T, Velpandian T, Kalaivani M, Pandey RM, Gao Y, Sabel BA, Dada R. Mindfulness Meditation Reduces Intraocular Pressure, Lowers Stress Biomarkers and Modulates Gene Expression in Glaucoma: A Randomized Controlled Trial. J Glaucoma. 2018 Dec;27(12):1061-1067. doi: 10.1097/IJG.0000000000001088.
PMID: 30256277BACKGROUNDSabel BA, Flammer J, Merabet LB. Residual vision activation and the brain-eye-vascular triad: Dysregulation, plasticity and restoration in low vision and blindness - a review. Restor Neurol Neurosci. 2018;36(6):767-791. doi: 10.3233/RNN-180880.
PMID: 30412515BACKGROUNDZhou W, Sabel BA. Vascular dysregulation in glaucoma: retinal vasoconstriction and normal neurovascular coupling in altitudinal visual field defects. EPMA J. 2023 Feb 16;14(1):87-99. doi: 10.1007/s13167-023-00316-6. eCollection 2023 Mar.
PMID: 36866155DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Bernhard A Sabel, PhD
University of Magdeburg
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Head of Institute, Professor
Study Record Dates
First Submitted
July 3, 2019
First Posted
July 30, 2019
Study Start
August 1, 2019
Primary Completion
December 31, 2022
Study Completion
August 1, 2023
Last Updated
February 9, 2021
Record last verified: 2021-02
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, CSR
- Time Frame
- After the results are published, unlimited duration
- Access Criteria
- Contact to the principal investigator
The results will be available without restriction